Correction: Awaji et al. Chemotherapeutic Activity of Imidazolium-Supported Pd(II) &lt;i&gt;o&lt;/i&gt;-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells. Here, ERBB2 is linked to breast carcinoma.